Diana Munoz Email & Phone Number

Eindhoven, Nb, Nl

Eindhoven, Nb, Nl

Geelen-The Netherlands

• Shaping product strategy and roadmap to address market needs, leading to impactful product development.• Leading cross-functional teams to ensure efficient workflow, knowledge transfer, and effective communication.• Conducting in-depth market research and competitor analysis to drive future product development at Promicol B.V.

Eindhoven, North Brabant, Netherlands

As a senior postdoctoral researcher, I'm responsible for designing, executing, and managing a proof of concept project. This project sits at the intersection of protein-protein interactions, Drug Discovery, and small molecules, making it both fascinating and challenging. My technical work involves cell-based assays to measure the biological activity of small molecules and protein-protein interaction detection & analysis methods such as Co-immunoprecipitation, Phosphoproteomics, and Crystallography. To ensure success, I collaborate with a wide range of suppliers, academic institutions, and biotech partners from Europe and the US. This experience has shown me the importance of selecting the right partners, processes, and workflows to reduce time-to-market and achieve success in the Biotech industry. I'm passionate about what I do and strive to make a difference in the fight against cancer.

Eindhoven, North Brabant, Netherlands

As chair of the PDA, I support the Postdoc community during their journey at TU/e. We have established regular social gatherings, workshops, and training with the support of the University. We plan to bring more ideas to the University to find solutions to the current postdoc community's challenges.

Amsterdam Area, Netherlands

During this time, our research was focused on identifying epigenetic modifiers with a potential role in the mesenchymal-adrenergic transition neuroblastoma (PMID: 28650485). In doing this, we use several primary and cancer neuroblastoma cell lines to investigate the effect of overexpressing and silencing epigenetic modifiersof interest. Moreover, we study subcellular localization, protein-protein interactions (i.e., coIPs, proteomics), and deposition patterns of histone-posttranslational modifications (ChIPseq, CUT&RUN).

1, Rue Laurent Fries 67404 Illkirch Cedex

In 2018, I moved to Strasbourg, France, for my first postdoc. Here, we investigated the progression of Friedreich's Ataxia (FA) cardiomyopathy and its active correction and identified dysregulated genes linked to central metabolism pathways. I also contributed to characterizing the transgenic FA mouse model and establishing the protocol to perform single-cell RNA sequencing analysis of dorsal root ganglia (DRG).

Valencia Area, Spain

2011, I started my PhD at the Universitat Polytechnic of Valencia (UPV) in Spain. My dissertation unraveled the link between mitochondrial dysfunction and cytoskeletal abnormalities in FA and the contribution of these events to the neurodegenerative process in the disease. Throughout the execution of the project, my research group underwent a series of relocations, transitioning from one esteemed research institute to another, including the prestigious IBV, the highly reputed Biomedical Institute of Valencia, the renowned Principe Felipe Research Center, and the esteemed University of Valencia. This dynamic experience bolstered my adaptability, fortifying my ability to collaborate with diverse teams and ensuring the resounding success of the research project.

Valencia, Spain

My academic journey in Europe began with pursuing a Master of Science degree in Biomedical Biotechnology from the esteemed Biomedicine Institute of Valencia. During my research, I explored the impact of low levels of a small mitochondrial protein on the structure and dynamics of actin filaments and microtubules in the growth cones of murine sensory neurons. My expertise in mouse and cellular models for Friedreich's ataxia (FA) is exemplary. Additionally, I have gained extensive experience working with confocal microscopy, primary-neuron cultures, and mammalian cell cultures. My passion for research and dedication to my work have enabled me to garner significant knowledge and expertise in my field.

Colombia

My scientific journey started in Colombia almost 11 years ago, studying novelanticancer compounds. During this time, I obtained substantial experience with cell cultures and methods of in vitro toxicology. This grateful experience aimed to pursue a scholarship from the Government of Colombia (Colciencias) to start my PhD in Valencia (Spain) in neurodegenerative diseases. In 2010, I was among the 200 selected from almost 800 candidates after a rigorous three-stage process.

Executive Mba, Business Administration And Management, General

The Executive MBA program at TIAS is taught in English and offers a comprehensive academic curriculum with a one-of-a-kind integrated.

Ph.D. In Biotechnology, Biomedical Sciences, General

M.Sc. Biomedical Biotechnology, Rare And Genetic Diseases/ Friedreich´S Ataxia

M.Sc. Biotechnology, Natural Compounds' Activity Against Cancer

B.Sc. Biological Engineering, Search For Biological Compounds Against Cancer